Is there a right to health?

Journal of Medicine and Philosophy

Volumn 30, Issue 6, 2005, Pages 643-662

  Goodman, Timothy ^a  

^a NONE

Author keywords

Health; Innovation; Pharmaceutical; Right

Indexed keywords

GOVERNMENT; GOVERNMENT REGULATION; HEALTH; HEALTH CARE; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HUMAN RIGHTS; LEGAL ASPECT; MEDICAL TECHNOLOGY; MEDICOLEGAL ASPECT; PATIENT CARE; RESPONSIBILITY; REVIEW; UNITED NATIONS; WELFARE; WORLD HEALTH ORGANIZATION;

ANALYTICAL APPROACH; HEALTH CARE AND PUBLIC HEALTH;

HEALTH; HEALTH POLICY; HUMAN RIGHTS; HUMANS; SOCIAL JUSTICE; UNITED NATIONS; UNITED STATES;

EID: 30544453437     PISSN: 03605310     EISSN: None     Source Type: Journal    
DOI: 10.1080/03605310500421413     Document Type: Review

References (32)

1. Aristotle, (1946). The politics (trans. E. Barker), London: Oxford University Press.
2. Bain & Company. (2004). Addressing the innovation divide. In Vivo, The Business and Medicine Report, 22(3).
3. Boston Consulting Group. (2004). Adverse Consequences of OECD Government Interventions in Pharmaceutical Markets on the U.S. Economy and Consumer.
4. Danzon, P. M., Wang, R., & Wang, L. (2003). The impact of price regulation on the launch delay of new drugs - Evidence from twenty-five major markets in the 1990s. NBER Working Paper, 9874.
5. Epstein, R.A. (2004, October 7). Does America have a prescription drug problem? The perils of ignoring the economics of pharmaceuticals. Institute for Policy Innovation Issue Brief.
6. Epstein, R.A. (1997). Mortal peril: Our inalienable right to health care?. New York: Addison Wesley Publishing Company.
7. Glendon, M.A. (1991). Rights talk: The impoverishment of political discourse. New York: The Free Press.
8. Goldwin, R.A. (1990). Why blacks, women, and Jews are not mentioned in the Constitution, and other unorthodox views. Washington, D.C.: The AEI Press.
9. Grant, M. (1978). History of Rome. Englewood Cliffs, N.J.: Prentice Hall.
10. Greene, J.P. (ed.) (1975). Colonies to Nation, 1763-1789: A documentary history of the American revolution. New York: W. W. Norton and Co.
11. Hayek, F. (1994). The road to serfdom. Chicago: University of Chicago Press.
12. Hayek, F. (1991). The fatal conceit: The failures of socialism. Chicago: University of Chicago Press.
13. Hill and Knowlton, Inc. (2005, January 27). Fortune 500 companies make top 10 in overall tsunami giving. (press release). Washington, B.C.: author.
14. Hunt, P. (2003, April). Preliminary report to the UN Commission on Human Rights. (E/CN.4/2003/58).
15. International Covenant on Civil and Political Rights (ICCPR), G.A. Res. 2200A (XXI), 21 U.N. GAOR Supp. (No. 16) at 52, U.N. Doc. A/6316 (1966), 999 U.N.T.S. 171, entered into force Mar. 23, 1976.
16. International Covenant on Economic, Social and Cultural Rights (ICESCR), G.A. res. 2200A (XXI), 21 U.N. GAOR Supp. (No. 16) at 49, U.N. Doc. A/6316 (1966), 993 U.N.T.S. 3, entered into force Jan. 3, 1976.
17. International Federation of Health and Human Rights Organizations (2004) The right to health: A resource manual for NGOs.
18. Kuehnelt-Leddihn, E. von. (1991). Leftism, revisted: From de Sade and Marx to Hitler and Pol Pot. Washington, DC: Regnery Publishing.
19. Locke, J. (2003). Two treatises of government and a letter concerning toleration. New Haven: Yale University Press.
20. Mansfield, H.C., Jr. (1993). Responsibility versus self-expression. In R.A. Licht (ed.), Old rights and new. Washington, DC: The AEI Press.
21. Muravchik, J. (2002). Heaven on earth: The rise and fall of socialism. New York: Encounter Books.
22. Pammolli, F., & Massimo, R. (2004). Market structure and drug innovation. Health Affairs, 23(1), 48-50.
23. Pharmaceutical Research and Manufacturers of America. (2003). Global partnerships: Humanitarian programs of the pharmaceutical industry in developing nations. [On-line]. Available http://world.phrma.org/global.partnership.2003. pdf.
24. Relman A.S.(2005, March 7). The health of nations. The New Republic. p. 23.
25. Ridley, D.B. (2005). Price differentiation and transparency in the global pharmaceutical marketplace. Pharmacoeconomics,, 23(7), 651-658.
26. Rousseau, J. (1968). The social contract. New York: Penguin Classics.
27. Smith, A. (1985). An inquiry into the nature and causes of the wealth of nations. New York: Modern Library.
28. United Nations Commission on Human Rights (UNCHR). (2005). [On-line]. Available : http ://www.unhchr.ch/html/menu2/2/chr.htm.
29. United Nations Global Compact. (2005) [On-line]. Available: http://www.unglobal compact.org/Portal/Default.asp?.
30. US Department of Commerce (2004) Pharmaceutical price controls in OECD countries: Implications for US consumers, pricing, research and development and innovation.
31. World Health Organization. (2002). World health report.
32. World Health Organization on health and human rights. (2005). [On-line]. Available: www.who.int/hhr/en/.